ENTITY
GNI Group

GNI Group (2160 JP)

12
Analysis
Health Care • Japan
GNI Group Ltd. develops therapeutic pharmaceutical products utilizing Genome analysis. The Company targets diseases indigenous to Asian countries. GNI controls the whole process of drug discovery by conducting clinical trials, research and development, and marketing. The Company owns global subsidiaries in China and the US.
more
Exchange Announcement • 07 Oct 2026 16:00

From The Growth Market To Topix: Gni Group Newly Selected In The First Periodic Review Following Topix Reform

Exchange Announcement • 03 Sep 2026 10:30

Promotion Of Proprietary Brand Business In The Medtech Segment

Exchange Announcement • 24 Aug 2026 07:30

Notice Regarding Change In Major Shareholder

Exchange Announcement • 18 Aug 2026 17:30

Q2 Fy2026 Financial Results Corporate Presentation

Exchange Announcement • 14 Aug 2026 15:00

Consolidated Financial Results For Q2 Fy2026 (Ifrs)

x